Janux Therapeutics, Inc.
SEC 4 · Filed
0001864159-26-000002Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Jan 2, 2026
- Security
- Common Stock
- Shares
-
1,879
- Price per share
-
13.73
Structured facts
{
"code": "S",
"date": "2026-01-02",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units."
},
"owners": [
{
"cik": "0001864159",
"name": "Meyer Andrew Hollman",
"roles": [
"officer"
],
"title": "Chief Business Officer"
}
],
"ownership": "D",
"post_shares": "83095",
"price": "13.73",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "1879",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}